AMSF Amerisafe (AMSF) Insider Trading, Ownership & Congress Trades
Insurance · Fire, marine & casualty insurance · CIK 0001018979
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
130
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · no price filed
What the filings say about AMSF
Congress, 1 year
No trades
Last one: sale, 2024-05-29
Amerisafe insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for AMERISAFE INC in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Nov 7, 2025.
- The trade is 49.1% of the 2,539 shares held after it.
- No other insider sold within 30 days.
- 130 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP-CFO Omiridis Anastasios sold about $50.1K of AMSF on Nov 20, 2025; 130 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Aug 5, 2025.
- The trade is 32.6% of the 3,786 shares held after it.
- No other insider sold within 30 days.
- 130 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP-CFO Omiridis Anastasios sold about $50.3K of AMSF on Nov 7, 2025; 130 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Sep 8, 2023.
- The trade is 59.6% of the 2,253 shares held after it.
- No other insider sold within 30 days.
- 130 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP-CFO Omiridis Anastasios sold about $60.1K of AMSF on Aug 5, 2025, the largest insider sale at the company since 2023; 130 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 9.9% of the 10,055 shares held after it.
- No other insider bought within 30 days.
- 130 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director BROWN MICHAEL J bought about $43.5K of AMSF on May 30, 2024, the largest insider purchase at the company since 2021; 130 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 218.8% of the 1,520 shares held after it.
- No other insider sold within 30 days.
- 130 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP-CFO Omiridis Anastasios sold about $170.3K of AMSF on Sep 8, 2023, the largest insider sale at the company since 2022; 130 funds added in the latest 13F quarter.15 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
130 funds bought in last quarter
below 56% of Insurance
Revenue
+2.7% year over year
below 73% of Insurance
Margin
14.9% net margin
more than 62% of Insurance
Buybacks
no share repurchases reported
Short interest
2.8% of the float short (float per yahoo 2026-10-26) · 1.0 days to cover · settled 2026-09-30
below 56% of Insurance
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch AMSF
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-35.4%12M
Insider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns AMSF: institutional holders (13F)
13F holdings, latest reported quarter
3,611,215 sh
$122.2M
1,278,305 sh
$43.2M
1,204,845 sh
$40.8M
824,222 sh
$27.9M
822,730 sh
$27.8M
Congress trades in AMSF
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2024-05-29 · disclosed 10 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
AMSF planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
AMSF mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Royce Small-Cap Total Return Fund
$14.7M position · as of 2026-06-30
1.5%
ETC 6 Meridian Small Cap Equity ETF
$1.2M position · as of 2026-05-31
1.0%
ProShares Russell 2000 Dividend Growers ETF
$5.6M position · as of 2026-05-31
0.9%
Invesco S&P SmallCap Low Volatility ETF
$1.8M position · as of 2026-05-31
0.8%
NVIT GS Small Cap Equity Insights Fund
$995.5K position · as of 2026-06-30
0.5%
Goldman Sachs Small Cap Value Insights Fund
$5.7M position · as of 2026-07-31
0.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$2.4M
$2.8M
$865.1K
+2%
+69%
2024
$2.3M
$2.7M
$937.9K
+29%
+51%
2023
$2.1M
$2.4M
$1.1M
+8%
+13%
2022
$1.5M
$2.2M
$817.9K
+9%
+7%
2021
$1.9M
$1.1M
$695.2K
+2%
+17%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 130 funds added last quarter. Each figure is a federal filing, dated the day it went public.
AMSF financials
Revenue growth
+2.7%
XBRL, annual
Net margin
14.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$335.6M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM AMSF
| FY Dec 2025 | $317.3M |
| FY Dec 2024 | $309.0M |
| FY Dec 2023 | $306.9M |
| FY Dec 2022 | $294.7M |
| FY Dec 2021 | $315.9M |
| Jun 2026 | $92.0M |
| Mar 2026 | $80.1M |
| Dec 2025 | $81.6M |
| Sep 2025 | $82.0M |
| Jun 2025 | $81.1M |
| Mar 2025 | $72.6M |
| Dec 2024 | $74.0M |
| Sep 2024 | $78.7M |
At each fiscal year end
Single quarter
Net margin, TTM
+14.0%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM AMSF
| FY Dec 2025 | +14.8% |
| FY Dec 2024 | +17.9% |
| FY Dec 2023 | +20.2% |
| FY Dec 2022 | +18.9% |
| FY Dec 2021 | +20.8% |
| Jun 2026 | +15.9% |
| Mar 2026 | +10.2% |
| Dec 2025 | +12.7% |
| Sep 2025 | +16.9% |
| Jun 2025 | +17.2% |
| Mar 2025 | +12.3% |
| Dec 2024 | +17.8% |
| Sep 2024 | +18.2% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$19.3M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM AMSF
| FY Dec 2025 | $8.9M |
| FY Dec 2024 | $23.4M |
| FY Dec 2023 | $29.3M |
| FY Dec 2022 | $26.1M |
| FY Dec 2021 | $36.7M |
| Jun 2026 | $1.8M |
| Mar 2026 | -$2.7M |
| Dec 2025 | $10.4M |
| Sep 2025 | $9.8M |
| Jun 2025 | -$9.5M |
| Mar 2025 | -$1.8M |
| Dec 2024 | $10.8M |
| Sep 2024 | $8.4M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity AMSF
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt AMSF
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+18.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity AMSF
| FY Dec 2025 | +18.5% |
| FY Dec 2024 | +20.2% |
| FY Dec 2023 | +20.4% |
| FY Dec 2022 | +15.5% |
| FY Dec 2021 | +15.7% |
| Jun 2026 | +18.2% |
| Mar 2026 | +18.2% |
| Dec 2025 | +18.5% |
| Sep 2025 | +16.9% |
| Jun 2025 | +17.8% |
| Mar 2025 | +16.9% |
| Dec 2024 | +20.2% |
| Sep 2024 | +18.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets AMSF
| FY Dec 2025 | +4.1% |
| FY Dec 2024 | +4.6% |
| FY Dec 2023 | +5.0% |
| FY Dec 2022 | +4.2% |
| FY Dec 2021 | +4.6% |
| Jun 2026 | +4.1% |
| Mar 2026 | +4.1% |
| Dec 2025 | +4.1% |
| Sep 2025 | +4.1% |
| Jun 2025 | +4.2% |
| Mar 2025 | +4.0% |
| Dec 2024 | +4.6% |
| Sep 2024 | +4.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital AMSF
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed AMSF
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.27x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing AMSF
| FY Dec 2025 | 15.55x |
| FY Dec 2024 | 17.90x |
| FY Dec 2023 | 14.48x |
| FY Dec 2022 | 18.05x |
| FY Dec 2021 | 15.88x |
| Jun 2026 | 13.64x |
| Mar 2026 | 13.72x |
| Dec 2025 | 15.55x |
| Sep 2025 | 16.86x |
| Jun 2025 | 16.63x |
| Mar 2025 | 21.28x |
| Dec 2024 | 17.90x |
| Sep 2024 | 15.10x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value AMSF
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+4.1%
TTM free cash flow over market value at close 2026-10-27
FCF yield AMSF
| FY Dec 2025 | +1.2% |
| FY Dec 2024 | +2.4% |
| FY Dec 2023 | +3.3% |
| FY Dec 2022 | +2.6% |
| FY Dec 2021 | +3.5% |
| Jun 2026 | +3.1% |
| Mar 2026 | +1.3% |
| Dec 2025 | +1.2% |
| Sep 2025 | +1.1% |
| Jun 2025 | +1.0% |
| Mar 2025 | +1.5% |
| Dec 2024 | +2.4% |
| Sep 2024 | +1.8% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -6%, PEG needs growth
PEG, trailing AMSF
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 1.19x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $317.3M | $309.0M | $306.9M | $294.7M |
| Net income | $47.1M | $55.4M | $62.1M | $55.6M |
| EPS (diluted) | 2.47 | 2.89 | 3.23 | 2.88 |
| Operating cash flow | $11.1M | $24.2M | $29.8M | $28.2M |
| Cash | $61.9M | $44.0M | $38.7M | $61.5M |
| Buybacks | n/a | n/a | $2.2M | $12.4M |
| Dividends paid | $48.6M | $85.4M | $93.3M | $100.4M |
SEC XBRL, fiscal years, as known on 2026-10-28
AMSF Stock Sonar score 4/7 axes
Find similar shapesCompareAMSF ranks highest on profitability (63rd percentile) and institutional and government (44th), and lowest on growth (27th), among Insurance peers.
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
AMSF filings, in plain words
Have members of Congress traded AMSF?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Josh Gottheimer dated 2024-05-29.
Read the full summary
Members of Congress have disclosed trades in AMSF, none in the last year; the latest on record is a sale by Josh Gottheimer dated 2024-05-29. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
